Hyderabad-based MapMyGenome launches MedicaMap to test efficacy of 165 medicines

Dec 05, 2022


Hyderabad, December 5, 2022: Hyderabad-based MapMyGenome, India‘s premier preventive genomics company, launched MedicaMap – a pharmacogenomics solution, the study of how a person‘s genetic makeup affects the metabolism of medications, on Sunday.

MedicaMap give an easy-to-read comprehensive report on medicines‘ toxicity and efficacy for a person. It guides clinicians to identify alternate medicine or adjust the dosage according to an individual‘s genetic profile for the prevention, diagnosis, and treatment of any health condition.

MapMyGenome CEO Anu Acharya gave a detailed presentation on MedicaMap followed by two panel discussions where eminent doctors discussed "pharmacogenomics in clinical setting" and "treat the patient, not the condition". Anu Acharya, at the launch event, said, "MedicaMap is a one of a kind pharmacogenomics product which provides detailed analysis of body‘s response to medicine based on genetic makeup. It is affordable, non-invasive and once-in-a lifetime. It can be done at home. We have introduced it at Rs.6,499 for over 165 drugs, which is probably the lowest price"

Disclaimer: The information provided here is not exhaustive by any means. Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.